Literature DB >> 20826109

Increased biomagnetic activity in healthy elderly with subjective memory complaints.

Fernando Maestu1, Evgenia Baykova2, José María Ruiz3, Pedro Montejo3, Mercedes Montenegro3, Marcos Llanero3, Elena Solesio4, Pedro Gil5, Raquel Yubero5, Nuria Paul6, Francisco Pozo2, Angel Nevado4.   

Abstract

OBJECTIVE: Subjective memory complaints (SMCs) are frequently reported by elderly people with or without objective cognitive impairment (OMI) as assessed by neuropsychological tests. We investigate whether SMCs are associated with altered brain biomagnetic patterns even in the absence of OMI.
METHODS: We report spatio-temporal patterns of brain magnetic activity recorded with magnetoencephalography during a memory task in 51 elderly participants divided into the following groups: patients with mild cognitive impairment (MCI) with SMC and OMI, individuals with SMC but not OMI, and healthy controls without neither SMC nor OMI. Exclusion criteria for all three groups included a diagnosis of depression or any other psychiatric condition.
RESULTS: No statistically significant differences were found between MCI patients and participants with SMC. However, the SMC showed higher activation, between 200 and 900 ms after stimulus onset, than the control group in posterior ventral regions and in the dorsal pathway. MCI patients showed higher activation than the control group in the posterior part of the ventral pathway.
CONCLUSIONS: These findings suggest that similar physiological mechanisms may underlie SMC and MCI, which could be two stages in a cognitive continuum. SIGNIFICANCE: MEG provide different neurophysiological profiles between SMC and control subjects.
Copyright © 2010 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20826109     DOI: 10.1016/j.clinph.2010.08.004

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

1.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

2.  Early dysfunction of functional connectivity in healthy elderly with subjective memory complaints.

Authors:  Ricardo Bajo; Nazareth P Castellanos; Maria Eugenia López; José María Ruiz; Pedro Montejo; Mercedes Montenegro; Marcos Llanero; Pedro Gil; Raquel Yubero; Evgenia Baykova; Nuria Paul; Sara Aurtenetxe; Francisco Del Pozo; Fernando Maestu
Journal:  Age (Dordr)       Date:  2011-04-06

3.  Magnetoencephalography as a putative biomarker for Alzheimer's disease.

Authors:  Edward Zamrini; Fernando Maestu; Eero Pekkonen; Michael Funke; Jyrki Makela; Myles Riley; Ricardo Bajo; Gustavo Sudre; Alberto Fernandez; Nazareth Castellanos; Francisco Del Pozo; C J Stam; Bob W van Dijk; Anto Bagic; James T Becker
Journal:  Int J Alzheimers Dis       Date:  2011-04-10

4.  The Virtual Trial.

Authors:  Willem de Haan
Journal:  Front Neurosci       Date:  2017-03-07       Impact factor: 4.677

5.  Altering neuronal excitability to preserve network connectivity in a computational model of Alzheimer's disease.

Authors:  Willem de Haan; Elisabeth C W van Straaten; Alida A Gouw; Cornelis J Stam
Journal:  PLoS Comput Biol       Date:  2017-09-22       Impact factor: 4.475

Review 6.  The Role of Magnetoencephalography in the Early Stages of Alzheimer's Disease.

Authors:  David López-Sanz; Noelia Serrano; Fernando Maestú
Journal:  Front Neurosci       Date:  2018-08-15       Impact factor: 4.677

7.  Memory complaint scale (MCS). Proposed tool for active systematic search.

Authors:  Francisco A C Vale; Ari P Balieiro; José Humberto Silva-Filho
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec

Review 8.  Functional neuroimaging in subjective cognitive decline: current status and a research path forward.

Authors:  Raymond P Viviano; Jessica S Damoiseaux
Journal:  Alzheimers Res Ther       Date:  2020-03-09       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.